130 related articles for article (PubMed ID: 24915852)
21. In vitro synergistic effects of metergoline and antifungal agents against Candida krusei.
Kang K; Wong KS; Seneviratne CJ; Samaranayake LP; Fong WP; Tsang PW
Mycoses; 2010 Nov; 53(6):495-9. PubMed ID: 19538518
[TBL] [Abstract][Full Text] [Related]
22. Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification.
Cabral ME; Figueroa LI; Fariña JI
Rev Iberoam Micol; 2013 Jan; 30(1):31-8. PubMed ID: 23069981
[TBL] [Abstract][Full Text] [Related]
23. Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time-kill methods.
Guo Q; Sun S; Yu J; Li Y; Cao L
J Med Microbiol; 2008 Apr; 57(Pt 4):457-462. PubMed ID: 18349365
[TBL] [Abstract][Full Text] [Related]
24. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
25. In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves.
Li Y; Sun S; Guo Q; Ma L; Shi C; Su L; Li H
J Antimicrob Chemother; 2008 Mar; 61(3):577-85. PubMed ID: 18194958
[TBL] [Abstract][Full Text] [Related]
26. The antifungal properties of chicken egg cystatin against Candida yeast isolates showing different levels of azole resistance.
Kolaczkowska A; Kolaczkowski M; Sokolowska A; Miecznikowska H; Kubiak A; Rolka K; Polanowski A
Mycoses; 2010 Jul; 53(4):314-20. PubMed ID: 19549107
[TBL] [Abstract][Full Text] [Related]
27. [In vitro resistance of Candida species to antifungal agents].
Banach-Piatkowska W; Kotłowski A; Humanowska J; Mayer L; Kowalczyk D
Wiad Parazytol; 2001; 47(4):811-6. PubMed ID: 16886432
[TBL] [Abstract][Full Text] [Related]
28. In vitro synergism between nyasol, an active compound isolated from Anemarrhena asphodeloides, and azole agents against Candida albicans.
Iida Y; Oh KB; Saito M; Matsuoka H; Kurata H
Planta Med; 2000 Jun; 66(5):435-8. PubMed ID: 10909263
[TBL] [Abstract][Full Text] [Related]
29. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
Venkateswarlu K; Denning DW; Kelly SL
J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
[TBL] [Abstract][Full Text] [Related]
30. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
Kobayashi T; Kakeya H; Miyazaki T; Izumikawa K; Yanagihara K; Ohno H; Yamamoto Y; Tashiro T; Kohno S
Jpn J Infect Dis; 2011; 64(4):292-6. PubMed ID: 21788703
[TBL] [Abstract][Full Text] [Related]
31. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K;
Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
[TBL] [Abstract][Full Text] [Related]
32. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
[TBL] [Abstract][Full Text] [Related]
33. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
34. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
Guo N; Ling G; Liang X; Jin J; Fan J; Qiu J; Song Y; Huang N; Wu X; Wang X; Deng X; Deng X; Yu L
Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756
[TBL] [Abstract][Full Text] [Related]
35. 2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents.
Emami S; Foroumadi A; Falahati M; Lotfali E; Rajabalian S; Ebrahimi SA; Farahyar S; Shafiee A
Bioorg Med Chem Lett; 2008 Jan; 18(1):141-6. PubMed ID: 18032039
[TBL] [Abstract][Full Text] [Related]
36. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans.
Endo EH; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
Res Microbiol; 2010 Sep; 161(7):534-40. PubMed ID: 20541606
[TBL] [Abstract][Full Text] [Related]
37. Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.
Pina-Vaz C; Rodrigues AG; Costa-de-Oliveira S; Ricardo E; Mårdh PA
J Antimicrob Chemother; 2005 Oct; 56(4):678-85. PubMed ID: 16115827
[TBL] [Abstract][Full Text] [Related]
38. Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods.
Cantón E; Pemán J; Gobernado M; Viudes A; Espinel-Ingroff A
Antimicrob Agents Chemother; 2005 Apr; 49(4):1593-6. PubMed ID: 15793148
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effect of chlorhexidine and azoles on candida biofilm on titanium surface.
Zhang H; Yi X; Chen M; Shi H; Tan L; Lu H; Sun Y; Yang F
J Mycol Med; 2023 Nov; 33(4):101417. PubMed ID: 37619456
[TBL] [Abstract][Full Text] [Related]
40. Purification, crystal structure and antimicrobial activity of phenazine-1-carboxamide produced by a growth-promoting biocontrol bacterium, Pseudomonas aeruginosa MML2212.
Shanmugaiah V; Mathivanan N; Varghese B
J Appl Microbiol; 2010 Feb; 108(2):703-11. PubMed ID: 19778345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
